The MedMemos Study: Promoting Adherence to Medications in Pediatric Bone Marrow Transplant Patients

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age0-12
SponsorNationwide Children's Hospital

About this trial

The goal of this clinical trial is to test the MedMemos Intervention with parents and children who have received a bone marrow transplant. The main study questions are:

* Is the MedMemos intervention acceptable to patients and families? * Is the MedMemos intervention feasible for patients, families, and healthcare providers? * Does MedMemos help patients and families take their medications better?

Participants will be asked to complete surveys, attend 4 intervention sessions, and use an electronic box or pill bottle to store their medications in.

Eligibility criteria

Qualifiers

Child had a Pediatric Allogeneic Hematopoietic Cell Transplant (PAHCT)

Child is 0-12 years of age

At the time of recruitment child is still in the hospital for PAHCT

Child's primary caregiver is responsible for administering medical care and is willing to give consent to participate

Disqualifiers

Caregiver does not speak English, Spanish, or Arabic

Caregiver is not available to provide written permission for the child's participation

EMR or medical team report of the caregiver's cognitive status precludes completion of questionnaires

The child's medical status or condition precludes completion of the study questionnaires as determined by the physician or caregiver

Trial design

Treatments tested in this trial

  • MedMemos

Treatment groups

25 Participants
are divided into 1 treatment group

Sponsors and collaborators